Loading...
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
TP53 mutations are strong predictors of poor survival and refractoriness in chronic lymphocytic leukemia (CLL) and have direct implications for disease management. Clinical information on TP53 mutations is limited to lesions represented in >20% leukemic cells. Here, we tested the clinical impact...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4017291/ https://ncbi.nlm.nih.gov/pubmed/24501221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-11-539726 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|